New Blood Test Screens for Colon Cancer - No S#!T

A new blood test screens for Colon Cancer and is covered by Medicare - No S#!T

Screening Colonoscopy remains the Gold Standard to screen for Colon Cancer and screening begins at 45. Cologard is the second best test to screen for colon cancer and is recommended for patients who refuse Colonscopy. Now there is a third option for screening for Colon Cancer which is non-invasive and cheaper than Colonoscopy and Cologard. No S#!T.

SHIELD is a FDA Approved blood test that screens for Colon Cancer.

SHIELD is covered by Medicare with 0 dollars co-pay.

SHIELD does not detect or treat (remove) precancerous adenomatous polyps. Because of this, Colonoscopy continues to be the Gold Standard to screen for Colon Cancer. For the 25-30% of women who refuse the Doctors order for Colonoscopy, consider SHIELD the new blood test that screens for Colon Cancer. Now available at Healthcare For Women in Oak Park, Illinois.

Author

Lyndon Taylor MD OB/GYN in practice for 44 years from Oak Park, Illinois

You Might Also Enjoy...

Screening for Syphilis during pregnancy

Untreated syphilis infection during pregnancy can be passed to the fetus, causing congenital syphilis. Congenital syphilis is associated with premature birth, low birth weight, stillbirth, neonatal death, and significant abnormalities in the infant.

Intermittent Fasting the 16:8 Method. Fasting is Fun and Drug Free

Popular Intermittent Fasting Schedule: 16:8 Method Fasting window: 16 hours (e.g., 8:00 PM – 12:00 PM next day) Eating window: 8 hours (e.g., 12:00 PM – 8:00 PM) When you eat follow the Mediterranean Diet. When you fast drink Black Coffee, Tea, Water.

Weight Loss Medications

Medications: Dual Action Decreases Urge to Eat and Reduces Appetite Contrave: Best for emotional/craving eaters Wegovy: Powerful, for general appetite/satiety Qsymia: Reduces appetite and urge to eat. Highly effective Phentermine: Short Term Use Only

Benefits of Contrast-Enhanced Mammography (CEM) for Dense Breasts

Dense breast tissue contains fibroglandular tissue which makes it hard to detect abnormalities on mammography. CEM improves visualization by highlighting areas of increased blood flow (often associated with tumors) through contrast uptake.

Prenatal Paternity Testing

Prenatal Paternity Testing involves a blood draw from the pregnant mother and a cheek swab from the alleged father. The test is over 99% accurate in confirming or excluding paternity. The test is performed at 10 weeks and results are delivered a week later

The M Factor - premiered on PBS on October 17, 2024, and is available for streaming on PBS.

The (M) Factor is a feature-length documentary that delves into the real-life experiences of women across the U.S. as they navigate menopause. It's a call to action to break the silence surrounding menopause.